This disruption of the tumor vasculature was confirmed by staining for CD31 (PECAM) which revealed multiple areas of discontinuity in EC comprising blood vessels and a statistically significant decrease in blood vessel density in the TM5441-treated group (P value = 0.002) (Fig 5F). This evidence concerns the gene PECAM1 and neoplasm.